Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 30, 2015

View Archived Issues

Bcl-2-like protein 11 is directly involved in beta cell apoptosis

TALENs used to disrupt gene for Rhesus D antigen in erythroid progenitor cells

Afferent Pharmaceuticals reports results from phase IIb trial of AF-219 in chronic cough

MPS1 inhibitor S-81694 begins first-in-human study for solid tumors

Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors

Aduro Biotech to acquire BioNovion

MedImmune and 3M Drug Delivery Systems collaborate to develop next-generation TLR agonists

Intercept Pharmaceuticals starts phase III trial of obeticholic acid in NASH with fibrosis

Verona releases data on new suspension formulation of RPL-554 in patients with COPD

FDA confirms data needed for Medidur NDA filing

BioMarin starts phase I/II trial of hemophilia A gene therapy BMN-270

Ablynx starts phase III trial of caplacizumab in acquired TTP

PDE4D is involved in Hedgehog signaling and could be targeted to treat medulloblastoma

CFTR gene therapy is associated with stabilization of lung function in phase IIb CF trial

F2G reports PK/PD profile of novel orotomide antifungal F-901318

IURTC and Assembly Biosciences patent HBV core protein allosteric modulators

Department of Health of the U.K. and JNCASR describe antimicrobial conjugates

Principia Biopharma reports TXK and ITK inhibitors

Merck & Co. and Merck Frosst Canada report HIV protease inhibitors

Takeda submits NDA for fixed-dose combination of Nesina and metformin in Japan

Endo confirms termination of waiting period for Par Pharmaceutical acquisition

Circulating miRNA levels associated with insulin resistance in metabolic syndrome

Maruho's Zebiax approved in Japan for bacterial skin infections

Topline results from third phase III trial of baricitinib for rheumatoid arthritis

Promising outcome in phase III ORATORIO study of ocrelizumab in primary progressive MS

FDA and EMA accept filings for rociletinib for NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...